Cytokine production and antitumor effect of a nonreplicating, noncytopathic recombinant vaccinia virus expressing interleukin-12

This publication has 15 references indexed in Scilit:

• A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus
  Vaccine, 1994
• Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo
  International Immunology, 1994
• Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
  The Journal of Experimental Medicine, 1993
• The interleukin‐12 subunit p40 specifically inhibits effects of the interleukin‐12 heterodimer
  European Journal of Immunology, 1993
• Interleukin-12 Promotes the Proliferation and Cytolytic Maturation of Immune Effectors
  Journal of Immunotherapy, 1993
• IL-12: Initiation Cytokine for Cell-Mediated Immunity
  Science, 1993
• Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants
  Virology, 1990
• Characterization of a factor(s) which synergizes with recombinant interleukin 2 in promoting allogeneic human cytolytic T-lymphocyte responses in vitro
  Cellular Immunology, 1988
• Prevention of vaccinia virus infection in imiminodeficient mice by vector-directed IL-2 expression
  Nature, 1987
• Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene
  Cell, 1981